Laura Parkkinen

8.4k total citations · 4 hit papers
47 papers, 4.4k citations indexed

About

Laura Parkkinen is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Laura Parkkinen has authored 47 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 20 papers in Physiology and 14 papers in Neurology. Recurrent topics in Laura Parkkinen's work include Parkinson's Disease Mechanisms and Treatments (38 papers), Neurological disorders and treatments (21 papers) and Alzheimer's disease research and treatments (17 papers). Laura Parkkinen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (38 papers), Neurological disorders and treatments (21 papers) and Alzheimer's disease research and treatments (17 papers). Laura Parkkinen collaborates with scholars based in United Kingdom, Finland and United States. Laura Parkkinen's co-authors include Irina Alafuzoff, Tuula Pirttilä, Hilkka Soininen, Janice L. Holton, Päivi Hartikainen, Tero Tapiola, Sanna‐Kaisa Herukka, Sean S. O’Sullivan, Erkki Kuusisto and Andrew J. Lees and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Brain.

In The Last Decade

Laura Parkkinen

45 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

2009 651 citations Irina Alafuzoff, Laura Parkkinen et al. profile →
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

2009 509 citations José Brás, Emma Deas et al. Brain profile →
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

2011 441 citations Laura Parkkinen, Sean S. O’Sullivan et al. Brain profile →
Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies

2016 420 citations Graham Fairfoul, Lynne I. McGuire et al. Annals of Clinical and Translational Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Parkkinen United Kingdom	26	3.1k	1.9k	1.0k	885	712	47	4.4k
Annika Öhrfelt Sweden	28	1.7k 0.5×	2.5k 1.3×	665 0.7×	1.1k 1.2×	1.3k 1.8×	40	4.7k
Susan Leight United States	19	1.5k 0.5×	2.2k 1.2×	953 0.9×	795 0.9×	1.2k 1.6×	21	3.9k
R. K. B. Pearce United Kingdom	41	3.8k 1.2×	1.0k 0.5×	2.1k 2.1×	861 1.0×	951 1.3×	78	5.7k
Isaac Veinbergs United States	21	1.8k 0.6×	1.6k 0.8×	1.6k 1.6×	696 0.8×	1.1k 1.5×	25	3.7k
Jordi Pérez‐Tur Spain	37	1.7k 0.5×	3.5k 1.8×	1.3k 1.3×	994 1.1×	2.2k 3.1×	91	5.6k
Heather L. Melrose United States	29	1.8k 0.6×	1.8k 0.9×	1.2k 1.2×	764 0.9×	1.2k 1.7×	38	3.7k
Nicholas M. Kanaan United States	37	1.6k 0.5×	2.5k 1.3×	1.6k 1.6×	930 1.1×	1.9k 2.7×	87	5.1k
Selina Wray United Kingdom	33	1.0k 0.3×	2.4k 1.2×	1.2k 1.2×	1.0k 1.1×	2.1k 2.9×	75	4.7k
Stephen N. Gomperts United States	24	1.0k 0.3×	1.3k 0.7×	1.1k 1.1×	380 0.4×	671 0.9×	49	3.2k
Kathryn A. Chung United States	23	1.8k 0.6×	707 0.4×	522 0.5×	390 0.4×	451 0.6×	39	2.6k

Countries citing papers authored by Laura Parkkinen

Since Specialization

Citations

This map shows the geographic impact of Laura Parkkinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Parkkinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Parkkinen more than expected).

Fields of papers citing papers by Laura Parkkinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Parkkinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Parkkinen. The network helps show where Laura Parkkinen may publish in the future.

Co-authorship network of co-authors of Laura Parkkinen

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Parkkinen. A scholar is included among the top collaborators of Laura Parkkinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Parkkinen. Laura Parkkinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Nanna Møller, et al.. (2025). Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathologica. 149(1). 41–41. 10 indexed citations

Stedehouder, Jeffrey, Bradley M. Roberts, Simon Bossi, et al.. (2024). Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes. Nature Communications. 15(1). 10017–10017. 8 indexed citations

Civitelli, Livia, et al.. (2024). Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. eLife. 13. 5 indexed citations

Paul, Kimberly C., Susan Searles Nielsen, Valerija Dobričić, et al.. (2024). Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputation. Brain Communications. 6(3). fcae146–fcae146. 2 indexed citations

Nassiri, Isar, Andrew Kwok, Katherine R. Bull, et al.. (2024). Demultiplexing of single-cell RNA-sequencing data using interindividual variation in gene expression. Bioinformatics Advances. 4(1). vbae085–vbae085. 1 indexed citations

Dobričić, Valerija, Marcel Schilling, Jessica Schulz, et al.. (2022). Differential microRNA expression analyses across two brain regions in Alzheimer’s disease. Translational Psychiatry. 12(1). 352–352. 33 indexed citations

Dobričić, Valerija, Marcel Schilling, I Farkas, et al.. (2022). Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains. Brain Communications. 4(6). fcac274–fcac274. 13 indexed citations

Liu, Alan King Lun, et al.. (2022). Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathologica Communications. 10(1). 163–163. 43 indexed citations

Poggiolini, Ilaria, Vandana Ayyar Gupta, Michael Lawton, et al.. (2021). Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain. 145(2). 584–595. 112 indexed citations

10.

Guella, Ilaria, Daniel M. Evans, Chelsea Szu‐Tu, et al.. (2016). α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease. Annals of Neurology. 79(6). 991–999. 69 indexed citations

11.

Fairfoul, Graham, Lynne I. McGuire, Suvankar Pal, et al.. (2016). Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies. Annals of Clinical and Translational Neurology. 3(10). 812–818. 420 indexed citations breakdown →

12.

Ruffmann, Claudio & Laura Parkkinen. (2016). Gut Feelings About α‐Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?. Movement Disorders. 31(2). 193–202. 49 indexed citations

13.

Taylor, Tonya, Dawid Potgieter, Steven L. Senior, et al.. (2013). Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease. 62. 193–207. 42 indexed citations

14.

Silveira‐Moriyama, Laura, Laura Parkkinen, Michael Farrell, et al.. (2012). A clinicopathological study of parkin-linked parkinsonism - A study of 5 cases and comparison with Parkinson's disease. UCL Discovery (University College London). 21(1). e47–e51.

15.

Brás, José, Emma Deas, Sean S. O’Sullivan, et al.. (2009). Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 132(7). 1783–1794. 509 indexed citations breakdown →

16.

Parkkinen, Laura, et al.. (2008). Systematic Appraisal Using Immunohistochemistry of Brain Pathology in Aged and Demented Subjects. Dementia and Geriatric Cognitive Disorders. 25(5). 423–432. 18 indexed citations

17.

Parkkinen, Laura, Päivi Hartikainen, & Irina Alafuzoff. (2007). Abundant glial α-synuclein pathology in a case without overt clinical symptoms. Clinical Neuropathology. 26(11). 276–283. 32 indexed citations

18.

Parkkinen, Laura, Tuula Pirttilä, Markku Tervahauta, & Irina Alafuzoff. (2005). Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject. Neuropathology. 25(4). 304–314. 58 indexed citations

19.

Kuusisto, Erkki, Laura Parkkinen, & Irina Alafuzoff. (2003). Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62. Journal of Neuropathology & Experimental Neurology. 62(12). 1241–1253. 219 indexed citations

20.

Parkkinen, Laura, Hilkka Soininen, & Irina Alafuzoff. (2003). Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease. Journal of Neuropathology & Experimental Neurology. 62(4). 363–367. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact